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Abstract
Background: Microarray technologies are widely used to quantify the abundance of transcripts
corresponding to thousands of genes. To maximise the robustness of transcriptome results, we
have tested the performance and reproducibility of rat and mouse gene expression data obtained
with Affymetrix, Illumina and Operon platforms.
Results: We present a thorough analysis of the degree of reproducibility provided by analysing the
transcriptomic profile of the same animals of several experimental groups under different popular
microarray technologies in different tissues. Concordant results from inter- and intra-platform
comparisons were maximised by testing many popular computational methods for generating fold
changes and significances and by only considering oligonucleotides giving high expression levels. The
choice of Affymetrix signal extraction technique was shown to have the greatest effect on the
concordance across platforms. In both species, when choosing optimal methods, the agreement
between data generated on the Affymetrix and Illumina was excellent; this was verified using qRT-
PCR on a selection of genes present on all platforms.
Conclusion: This study provides an extensive assessment of analytical methods best suited for
processing data from different microarray technologies and can assist integration of technologically
different gene expression datasets in biological systems.
Background
Microarray analysis is an established method of investi-
gating the transcription levels of many thousands of genes
simultaneously [1]. Several technologies have been devel-
oped, differing in array design, manufacturing procedure
(standardised printing or randomised microbeads),
experimental design (absolute or relative expression
level), target oligonucleotide sequence length, hybridisa-
tion and image analysis. The most advanced and widely
used technologies for high throughput gene transcription
studies are Affymetrix® GeneChip® [2] and Illumina® Sen-
trix® BeadChip arrays [3], which both allow the quantifi-
cation of the amount of tens of thousands of transcripts.
Custom arrays of oligonucleotides have also been used
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data can be integrated with these more advanced technol-
ogies.
On Affymetrix arrays, genes are represented by one or
more probe sets, which are short oligonucleotides (25
base pairs) covering distinct sections of the gene synthe-
sised in place through photolithography. Illumina Bead-
Chips® have an entirely unique layout of 50 base pairs
long oligonucleotides synthesised in a separate procedure
and attached covalently to silica beads, which are ran-
domly dispersed over the array so that they each lie in an
unique well [4]. This random allocation of beads means
that each oligonucleotide is represented a random
number of times on each array (on average 30 times).
Custom microarrays consist of long oligonucleotides (75
base pairs for Operon), printed onto a glass array in a reg-
ular arrangement, so that all arrays have an identical oli-
gonucleotide layout [5]. In contrast to Affymetrix and
Illumina arrays which measure the transcriptome of one
sample at a time, Operon and many other custom arrays
utilise two dyes to assess comparative gene expression of
two samples on the same chip.
The evaluation of the reproducibility of biological results
across microarray platforms is essential for interpreting
data independently generated with different technologies
and reducing the need to duplicate experiments. Tran-
scriptomic platforms produce both random and system-
atic errors in predicting actual biological changes. When
data from two platforms are compared, the two platform-
specific systematic errors are combined with the random
error, hence the superior platform which minimises its
own systematic errors should have higher agreement with
the other platforms.
Growing interest in testing consistency of gene transcrip-
tion results from different sources has paralleled the
increasing number of genome-wide gene expression data-
sets and the emergence of various microarray platforms
and technologies [6]. Some studies comparing data from
oligonucleotide arrays and cDNA arrays showed good cor-
relation between intensities and/or fold changes of gene
expression [6-8] whilst others reported poor consistency
[9,10]. Affymetrix data showed good concordance with
those from other oligonucleotide arrays, including Illu-
mina, [11-14] although some studies recommended the
use of solely highly expressed genes [8,15].
Studies on multiple platforms have found generally poor
reproducibility across gene expression platforms [16,17],
although this reproducibility was found to vary between
laboratories [18]. The MicroArray Quality Control project,
however, compared data from six commercial platforms
and an array spotted with Operon oligonucleotides found
high inter-platform concordance for differentially
expressed genes, as well as better intrasite reproducibility
for Illumina and higher intersite concordance for Affyme-
trix, and fold change reduction for the Operon dataset [6].
Additionally, Quantitative Real Time Polymerase Chain
Reaction (qRT-PCR) has been used by a number of studies
[17,19-21] as an independent highly reliable gene expres-
sion measurement for comparison.
Although numerous methods have been developed for
transcriptomic data analysis, the vast majority of these
studies used only one method of data normalisation for
each platform, and a single agreement measure (for exam-
ple fold change), hence many methodologically biases
may not be recognised. Here we report the first compara-
tive analyses of multiple gene transcription data sets
obtained in parallel with different microarray technolo-
gies over several popular normalisation methods using
multiple cross-platform concordance criteria. We use bio-
logically-relevant transcriptomic data for the mouse and
rat genomes in the context of insulin resistance in inbred
strains. Probe alignment was performed both by sequence
identity and assignment to the Ensembl Gene database.
After applying multiple background, intra- and inter-array
effect corrections and signal extraction and probe summa-
risation techniques, we demonstrate the factors affecting
the concordance of both magnitude and statistical signif-
icance of the transcriptomic effects between platforms.
Results
To test the performance of widely used microarray tech-
nologies in generating consistent genome-wide gene
expression data and to assess the effects of various calibra-
tion methods on the degree of cross-platform data repro-
ducibility in terms of magnitude and statistical
significance of gene expression changes, we used tran-
scriptomic profiles of various mouse and rat organs
derived with different microarray systems.
Analysis of overall levels of inter-platform gene 
concordance
To determine the degree of consistency in gene content
between platforms, we initially tested both individual oli-
gonucleotide mapping and gene level agreements. In the
mouse arrays, we aligned 8,901 Illumina oligonucleotides
to Affymetrix probe sets using "target sequence" identity
and a total of 14,242 Ensembl genes were overlapping
between the two platforms. In the rat arrays, analysis of
gene level matches via the Ensembl gene database allowed
the identification of a core of 1,804 individual genes rep-
resented on all three platforms, as opposed to 149 using
"target" sequence identity, thus enabling a more reliable
three-way comparison to be made.Page 2 of 13
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To test the capacity of the microarray platforms to capture
and record changes in probe binding, we then carried out
pairwise comparative analysis of the raw intensity signals
generated by the platforms. In both rat and mouse data-
sets, the Pearson correlation (r) between the measured
intensities for gene matches between any two platforms
for all experiments was greater than 0.7, and the majority
greater than 0.8. In the rat datasets, the minimal Illumina-
Operon pairwise correlations were all greater than 0.8 for
all strain comparisons (Table 1). Data from Affymetrix
and Illumina arrays were also highly concordant with
minimal and maximal correlation values ranging between
0.795 and 0.889, respectively. These high correlation lev-
els imply that the programs used have successfully aligned
genes between platforms and that in the vast majority of
cases expression of the same genes are measured with dif-
ferent platforms and technologies. However, these results
also indicate that platform differences do exist (e.g.
hybridisation efficiencies, probe design and data process-
ing), disallowing direct data integration. We therefore
analysed changes in gene expression between animals
under different experimental conditions as the means of
comparison.
We verified that genes whose expression level is low com-
pared to all genes on the same microarray produce less
reproducible results. This may be caused by the increased
influence of background noise on the intensity of the sig-
nal generated by the hybridization of the experimental
probe to the oligonucleotides. Therefore for many com-
parisons, all data were filtered so that only the most
intense 25% of all oligonucleotides on an array was con-
sidered, a comparable proportion to that which the
microarray manufacturers' own software calculated for
percentage of genes "present" (Additional files 1 and 2).
Numerical analysis of fold change of gene expression
The magnitude of gene expression changes, alongwith the
statistical significance of the effects, is an important crite-
rion in data analysis that assists the selection of genes for
further functional investigations. When comparing data
across platforms, the signal extraction or calibration tech-
niques used had little impact on the correlations in the
logarithm of the absolute intensity measure (Pearson cor-
relations r were approximately 0.8), but had a large
impact when correlating fold changes for the Illumina
and Affymetrix mouse datasets (see Additional file 3).
In the mouse C57BL/6J diet comparisons, the Affymetrix-
Illumina inter-platform correlations in the gene expres-
sion fold changes on the logarithmic scale attained using
selected normalisations at decreasing levels of filtering for
alignments based on sequence identity showed concord-
ant levels with Ensembl gene based alignments and "tar-
get matches" (Tables 2 and 3). The correlation was
excellent, exceeding 0.7 for all probes for certain pairs of
normalisations, approaching 0.9 for the suggested filter-
ing, and surpassing 0.95 when only the most intense sig-
nals were analysed. Generally higher inter-platform
agreement was found when using the Ensembl Gene
alignments.
For the comparison between gene expression data from
rat models derived by Affymetrix, Illumina and Operon
microarrays, pairwise platform fold-change correlations,
using signal extractions and normalisations selected to
maximise the concordance, were derived for all genes and
the selection of 25% of genes giving the most intense sig-
nals (Figure 1). The liver data set provided higher inter-
platform agreements than the kidney results, perhaps due
to higher tissue heterogeneity in total kidney than in liver.
Multiple strain comparisons were used and often had
large impacts on the agreement of the platforms. For the
most consistent rat group comparisons (eg. STZvsWKY
and GKvsWKY), the correlation between pairs of plat-
forms for intensity-filtered data always exceeded 0.8, with
gene level correlation above 0.96 for the STZvsWKY
Affymetrix and Illumina comparison. Results from these
two platforms were the most concordant, and, if the rec-
Table 1: Maximum and minimum intensity correlations between platforms.
Affymetrix/Illumina Illumina/Operon Operon/Affymetrix
Max. Min. Max. Min. Max. Min.
Liver BN vs WKY 0.889 0.808 0.848 0.826 0.844 0.776
GK vs BN 0.887 0.802 0.846 0.824 0.844 0.773
GK vs WKY 0.887 0.805 0.846 0.824 0.848 0.781
STZ vs GK 0.887 0.804 0.844 0.823 0.841 0.768
STZ vs WKY 0.889 0.809 0.845 0.825 0.840 0.772
Kidney BN vs WKY 0.874 0.795 0.832 0.809 0.828 0.754
GK vs BN 0.876 0.796 0.827 0.805 0.822 0.749
GK vs WKY 0.874 0.795 0.829 0.806 0.825 0.751
Data are given for all pairwise platform comparisons for all Affymetrix, Illumina and Operon Ensembl Gene amongst all normalisations, for all liver 
and kidney rat data.Page 3 of 13
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Operon platform agrees most with the Affymetrix plat-
form, suggesting that Affymetrix may be platform generat-
ing the most reproducible data.
To verify this, we conducted quantitative RT-PCR (qRT-
PCR) analysis of the expression of a selection of genes in
the rat kidney (see Additional file 4) and calculated corre-
lations between fold changes of gene expression between
the rat models given by qRT-PCR and the three microarray
Table 2: Correlations (log2 fold change) between Illumina and Affymetrix mouse "target matches" for selected normalisations.
Affymetrix normalisations
Filter (app. N) Illumina normalisations Scale – Avgdiff Quantile-median polish MAS 5.0 Li-Wong RMA GC-RMA vsn
5% (560) Quantile 0.936 0.946 0.936 0.941 0.949 0.949 0.946
Loess 0.940 0.945 0.944 0.944 0.949 0.949 0.954
Rank 0.941 0.947 0.944 0.945 0.951 0.951 0.953
vsn 0.940 0.947 0.945 0.947 0.952 0.952 0.953
10% (1125) Quantile 0.922 0.936 0.920 0.932 0.940 0.944 0.939
Loess 0.922 0.932 0.925 0.933 0.939 0.943 0.944
Rank 0.924 0.935 0.925 0.934 0.941 0.944 0.944
vsn 0.921 0.933 0.926 0.937 0.943 0.946 0.942
25% (2700) Quantile 0.843 0.875 0.836 0.857 0.893 0.887 0.883
Loess 0.834 0.868 0.834 0.854 0.888 0.884 0.882
Rank 0.843 0.874 0.838 0.859 0.894 0.887 0.886
vsn 0.826 0.860 0.844 0.863 0.897 0.890 0.873
50% (4600) Quantile 0.760 0.807 0.596 0.730 0.824 0.825 0.816
Loess 0.746 0.800 0.596 0.725 0.818 0.823 0.813
Rank 0.759 0.805 0.598 0.731 0.825 0.825 0.817
vsn 0.724 0.766 0.607 0.728 0.807 0.814 0.780
100% (10018) Quantile 0.666 0.732 0.289 0.428 0.732 0.739 0.735
Loess 0.645 0.722 0.285 0.421 0.724 0.735 0.730
Rank 0.653 0.721 0.286 0.422 0.723 0.731 0.727
vsn 0.590 0.647 0.280 0.402 0.670 0.674 0.656
The percentages indicate the percentile cut-off for the intensity on both platforms as well as an approximate number of matches (app. N) selected 
(normalisation-dependent).
Table 3: Correlation (log2 fold change) between Illumina and Affymetrix mouse Ensembl gene matches for selected normalisations.
Affymetrix normalisations
Filter (app. N) Illumina normalisations Scale – Avgdiff Quantile-median polish MAS 5.0 Li-Wong RMA GC-RMA vsn
5% (400) Quantile 0.942 0.949 0.937 0.944 0.951 0.945 0.953
Loess 0.948 0.950 0.946 0.948 0.952 0.948 0.959
Rank 0.947 0.951 0.944 0.947 0.953 0.948 0.959
vsn 0.949 0.954 0.947 0.948 0.957 0.951 0.961
10% (900) Quantile 0.928 0.938 0.922 0.935 0.947 0.947 0.942
Loess 0.930 0.936 0.928 0.937 0.946 0.947 0.947
Rank 0.930 0.937 0.927 0.937 0.947 0.948 0.946
vsn 0.928 0.935 0.927 0.935 0.946 0.946 0.944
25% (2600) Quantile 0.864 0.885 0.867 0.869 0.898 0.896 0.894
Loess 0.860 0.881 0.869 0.866 0.895 0.894 0.895
Rank 0.865 0.884 0.870 0.869 0.898 0.897 0.896
vsn 0.858 0.880 0.876 0.874 0.905 0.904 0.892
50% (15600) Quantile 0.781 0.820 0.689 0.766 0.826 0.825 0.829
Loess 0.772 0.815 0.688 0.760 0.821 0.822 0.828
Rank 0.781 0.819 0.691 0.766 0.826 0.825 0.830
vsn 0.758 0.796 0.695 0.768 0.822 0.819 0.809
100% (14242) Quantile 0.662 0.724 0.284 0.417 0.712 0.722 0.727
Loess 0.646 0.718 0.280 0.407 0.704 0.718 0.723
Rank 0.650 0.715 0.280 0.410 0.704 0.714 0.720
vsn 0.595 0.652 0.275 0.397 0.660 0.666 0.659
The percentages indicate the percentile cut-off for the intensity on both platforms as well as an approximate number of matches (app. N) selected. 
This number is normalisation-dependent.Page 4 of 13
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changes generated, and those found by Affymetrix and
Illumina were both outstanding, exceeding a Pearson cor-
relation of 0.976. However, these high correlation values
may be, at least partly, due to the small number of genes
tested, with an over-representation of differentially-
expressed genes. Correlation levels with data from the
Operon platform were lower for the three comparisons
tested (BNvsWKY, GKvsBN and GKvsWKY), but Operon
data were not available for the strain comparisons produc-
ing the highest correlations between qRT-PCR and Illu-
mina or Affymetrix data (STZvsGK and STZvsWKY).
Concordance of gene lists
To determine the level of agreement in the list of genes
found differentially expressed with the microarray plat-
forms tested, we analysed both fold changes and p values
for genes showing the most significantly altered expres-
sion. We found that the cross-platform agreement in p val-
ues was lower than that of fold changes, which is iin
agreement with previous observations [6]. This can be
explained by the dependence of p value on variance which
is ignored in the fold change calculation and is likely to be
platform-dependent.
For the mouse dataset (see Additional files 3, 5, 6), less
than half of the matches are in common in Illumina and
Affymetrix arrays, which may be lower than expected. For
the rat data set, the level of agreement between platforms
in gene expression fold changes was dependent on the
strain comparison (see Additional file 7). This may due to
the important magnitude of the expression differences
between the most severely affected rats (STZ-WKY) com-
pared to a control strain (WKY), as the most differentially
expressed genes have highly dispersed fold changes, hence
easier to reproduce. On the other hand, only small pheno-
typic differences between two control strains (BN and
WKY) may generate much more reduced gene expression
differences that may be more susceptible to be masked by
variations in the background (see Additional files 1 and
2).
In order to illustrate the extent of all intra-platform con-
cordances simultaneously, we developed a novel "dart-
board" plot (Figures 3 and 4). This system allows the
visualisation of strongly concordant or discordant results
for subsets of genes selected for various expression fold
changes and p values. In the example of gene expression
fold changes shown in Figure 3, 17 of the top 20 genes in
the Illumina gene list appeared in the top 50 genes as
ranked by the Illumina data, whereas all of the top 20
genes from Affymetrix are ranked in the top 50 genes by
Illumina. There was excellent agreement in the top fold
change lists of genes differentially expressed for all three
platforms (Figure 3 and Additional file 7), again greater
than for the p values (Figure 4 and Additional file 8).
These results indicate that if the highly-differentially
expressed genes are present on all arrays, they will reliably
be called by any of these platforms. However, in this
experiment the number of genes on each platform was
very different, so that the full lists will be more dissimilar.
Overall, Affymetrix achieved high correlations over all
strain comparisons, whereas Illumina ranked highest for
the comparisons with the strongest transcriptomic diver-
gences, although this difference is marginal. This suggests
that Illumina may be the most appropriate platform when
investigating highly expressed genes with large fold
Comparisons of gene expression changes between platforms in all r t microarray datasetFigu e 1
Comparisons of gene expression changes between 
platforms in all rat microarray datasets. Correlation in 
log2 fold change between Affymetrix, Illumina and Operon 
Ensembl Gene matches were calculated for all tissues and 
strain comparisons for all matches (squares) and 25% inten-
sity-filtered data (circles). Illumina data were normalised by 
loess normalisation for liver and quantile normalisation for 
kidney. Affymetrix data were normalised by RMA and 
Operon data by vsn-scale.
Correlations between qRT-PCR and microarray resultsFigure 2
Correlations between qRT-PCR and microarray 
results. Maximum correlations (log2 fold change) between 
qRT-PCR and array results in rat kidneys are given for all 17 
genes in all strain comparisons, maximising correlation over 
all normalisations.Page 5 of 13
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marginal gene expression changes.
Effects of normalisation methods on inter-platform concordance
Numerical analysis of fold change of gene expression
Gene expression profiling data were used to compare the
various calibration techniques employed in this study.
The signal extraction model had a much larger effect on
the analysis than the subsequent normalisation (data not
shown). The Affymetrix signal extractions showed a much
larger heterogeneity than the background corrections and
normalisations used on the other platforms. This is largely
due to the more complex design of the Affymetrix micro-
arrays, including the presence of distinct oligonucleotides
in a probe set and mismatch probes, which are handled
differently. The difference was greatest at low fluores-
cence. In the mouse dataset, the Li-Wong method and
MAS 5.0 had high variance (Tables 2 and 3) and filtering
was required. In terms of correlation in fold change of
gene expression, RMA, GC-RMA and vsn consistently
showed the highest agreement with other platforms,
whereas MAS 5.0 and the Li-Wong method require high
levels of filtering for a similar performance. For Illumina,
the differences were less marked with the vsn method pro-
ducing slightly lower inter-platform correlations. The
Operon methods showed little discordance.
When qRT-PCR data derived in rats for a small election of
genes were used to assess the effects of normalisation
methods on microarray-based gene expression data, we
found that for Affymetrix, MAS 5.0, RMA, GC-RMA and
the Li-Wong method all had very high correlations with
the logarithm of the qRT-PCR fold change, and the high-
est was comparison-dependent (see Additional file 9). For
Illumina, vsn normalisation correlated the most with the
qRT-PCR data, although only small differences were
observed (see Additional file 10). For Operon (see Addi-
tional file 11), the vsn transformation correlates least of
all, with the Kooperberg background correction produc-
ing the most concordance.
In the mouse data set, the Affymetrix methods without
background correction showed similar magnitude of fold
changes to all techniques applied to Illumina data, except
vsn, whereas the other Affymetrix methods showed higher
fold changes (see Additional file 12). For the rat data set,
we are able to analyse for each rat group comparison, fold
changes obtained for each platform against those gener-
ated by qRT-PCR (see Additional file 13). All Operon tech-
niques slightly over-estimated the fold change, whereas all
Illumina data slightly under-estimated the change com-
pared to qRT-PCR. For Affymetrix, MAS 5.0 and GC-RMA
were most accurate, RMA and Li-Wong provided slight
Cross-platform comparisons of fold changes in the liver tran-sc iptome analyses between WKY-STZ and WKYFigure 3
Cross-platform comparisons of fold changes in the 
liver transcriptome analyses between WKY-STZ and 
WKY. "Dartboard" plots were derived using all Ensembl 
gene matches between Affymetrix (scale-median polish), 
Operon (vsn-scale) and Illumina (loess). The number repre-
sents the agreement in absolute log2 fold changes for all 
genes (left, 1,804 genes) and the top 25% most intense genes 
(right, approximately 280 genes) on all three platforms (see 
methods). Gene lists generated by the platforms indicated in 
large block capitals are entered inwards from the circumfer-
ence and compared to gene lists generated by the other two 
platforms on either side of the dotted line. Segments are col-
our coded so that red marks the maximum possible value for 
a given comparison, and white represents less than half of the 
maximum.
Cross-platform comparisons of p-values in the liver tran-sc iptome analyses between WKY-STZ a d WKYFigure 4
Cross-platform comparisons of p-values in the liver 
transcriptome analyses between WKY-STZ and 
WKY. "Dartboard" plots were derived using all Ensembl 
Gene matches between Affymetrix (scale-median polish), 
Operon (vsn-scale) and Illumina (loess). The number repre-
sents the agreement in p values for all genes (left, 1502 
genes) and the top 25% most intense genes (right, approxi-
mately 280 genes) on all three platforms (see methods). 
Gene lists generated by the platforms indicated in large block 
capitals are entered inwards from the circumference and 
compared to gene lists generated by the other two platforms 
on either side of the dotted line. Segments are colour coded 
so that red marks the maximum possible value for a given 
comparison, and white represents less than half of the maxi-
mum.Page 6 of 13
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large under-estimation of fold changes.
Concordance in gene lists
Finally we tested the effect of normalisation methods on
the concordance in the lists of genes found differentially
expressed with different platforms. Amongst Affymetrix
signal extraction methods, MAS 5.0 showed the lowest
agreement in fold change and p value when using all
matches, but agreement was good with high filtering
(Tables 2 and 3, Additional file 12). The Li-Wong method
provided low inter-platform fold change correlation, but
excellent agreements in p values and (for only the most
extreme filtered oligonucleotides) fold changes. The RMA
and GC-RMA performed well in these tests. No consistent
differences were found for Illumina normalisations. The
loess normalisation was superior for the Illumina experi-
ment in rat liver, but it was quantile normalisation which
agreed most for the rat kidney transcriptomic dataset. For
Operon data, using the vsn transformation had the high-
est agreements in the top gene lists sorted by absolute fold
change or p value.
Overall, when no filtering was applied, the factors deter-
mining most concordance between platforms, in approx-
imate order of importance, were: Affymetrix signal
extraction, group comparison, organ and between-array
normalisations (all platforms) (see for example Addi-
tional files 7 and 8). If filtering was applied, however,
group comparisons and organ were most important with
more similar performance by all signal extractions.
Discussion
We have carried out an extensive assessment of the per-
formance of three gene expression profiling platforms
designed for two mammalian genomes and provide infor-
mation on analytical methods that are best suited to
processing data from specific types of arrays. Even though
comparisons of data from multiple microarray technolo-
gies have been extensively tested [7,21], including in
advanced high density array systems such as Illumina and
Affymetrix [11], we more specifically focused on the
impact of normalisation methods on multiple concord-
ance criteria (raw intensity, expression ratio, statistical sig-
nificance), which remain partly addressed in the
literature, to assess the extent of cross-platform data con-
sistency and divergence. Overall, using genome-wide gene
expression profiling data of rat and mouse genomes we
provide confirmatory evidence of the extremely high
agreement between platforms as previously suggested [8],
and the particularly high consistency of results at a gene
level between Illumina and Affymetrix [11]. Both plat-
forms agree less well with Operon-generated data, and
this technology also correlates less well with independent
qRT-PCR data. Both Illumina and Affymetrix had out-
standing correlation with qRT-PCR results, indicating that
they produce highly reliable fold change results on a gene
level, even for a modest number of biological replicates.
Multiple strain comparisons were used and often had
large impacts on the agreement of results from the plat-
forms, due mainly to genetic differences. The comparison
between inbred rat strains for hepatic and renal gene
expression, which was repeated on Affymetrix, Illumina
and Operon microarrays, showed that the kidney
appeared to produce less reproducible data, perhaps due
to morphological heterogeneity of this organ. However,
the correlation between the fold changes generated by
qRT-PCR, a highly reliable method of measuring tran-
scription [20,22] and those found by Affymetrix and Illu-
mina were outstanding, exceeding a Pearson correlation
of 0.976.
Perhaps surprisingly, correlations achieved between these
microarray systems and the independent qRT-PCR tech-
nique were higher than the inter-platform comparisons
using sequence or Ensembl Gene matching techniques,
and even higher than between distinct normalisations on
the same platform. However, those methods attempted to
match oligonucleotides on a genome-wide level, while
qRT-PCR comparisons use a small number of known
genes, specifically chosen for their biological role and/or
high differential expression in the microarray experi-
ments.
Data from our cross-platform comparisons were
improved by methods for probe alignment, which were
based on sequence identity and assignment to the
Ensembl. The majority of published cross-platform analy-
ses have used methods based on identifiers (eg. gene
names and accession numbers), which represent signifi-
cant challenges due to the existence of synonyms and
evolving or inconsistent annotations. Our inter-platform
correlations in log fold changes and agreements in the
most affected genes obtained using "target" sequence
identity were often surpassed by aligning the oligonucle-
otides to Ensembl gene sequences. This is surprising, as
the precise matching of oligonucleotide sequences within
a gene provided by "target matching" is expected to be
most reproducible, as the effects of complicating factors,
such as alternative splicing, are reduced. However, the
removal of poorly annotated probes in a probe set and
combining information across entire genes create more
reproducible results, and demonstrate the power of this
novel alignment tool.
The Affymetrix signal extractions showed a much larger
heterogeneity than the background corrections and nor-
malisations used on the other platforms. This is largely
due to the way the methods treat the more complicatedPage 7 of 13
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sequences in a probe set and MM probes).
RMA was the method which performed consistently well
in all comparisons. It produced high correlation in log
fold change of gene expression between platforms, regard-
less of filtering, annotation or biological comparison and
high agreement in gene lists for both statistical signifi-
cance and fold change magnitude. However, the fold
change can be underestimated by RMA [23]. This was sug-
gested by the mouse study, in comparison with Illumina,
and the rat kidney comparison with qRT-PCR data,
although fold changes of gene expression in the rat data-
sets were comparable with those from Illumina and
Operon arrays. The related method GC-RMA also per-
formed very well in a large number of comparisons [24],
correlating the most in terms of intensity, having high cor-
relation in gene expression fold changes, high agreement
in most gene lists, and producing comparable gene
expression fold changes with qRT-PCR. However, it pro-
duced lower correlations with Operon and lower p value
agreement for the rat liver dataset.
The Affymetrix own method MAS 5.0 and the popular Li-
Wong method showed very mixed results, especially
extreme for MAS 5.0. These methods showed poor agree-
ment with other platforms when all genes were used, but
occasionally produced excellent results when intensity-
based filtering was utilised. These methods often showed
extremely high agreement in top fold change and (espe-
cially Li-Wong) p value lists. These two methods also pro-
duced very high correlations with the qRT-PCR data, and
MAS 5.0 fold change was almost identical. These findings
suggest that these methods may be useful when searching
for large effect sizes in highly-expressed known genes, but
are poor for whole genome studies or detection of effects
of small magnitude. Other Affymetrix normalisations,
which used the PM values without correction often
showed intermediate results. This implies that using
either the mismatch values or a statistical framework to
calculate and remove background effects is likely to
improve the accuracy, sensitivity and reproducibility of
transcriptomic data generated using the Affymetrix plat-
form.
Conclusion
Testing multiple analytical methods in microarray experi-
ments is essential to maximise the robustness of results of
gene transcription profiling in terms of metabolic and
hormonal regulations of systems and interpretations of
biological processes. This study provides an exhaustive
and stringent assessment of analytical methods best suited
for processing data from different microarray-based gene
expression profiling technologies. These results are impor-
tant for comparing transcriptomic data generated with dif-
ferent platforms and explaining inconsistencies between
results that can be reanalysed using the most appropriate
method. Our analyses can assist the integration of gene
expression data obtained with different technologies in a
single biological system.
Based on results from our analyses, the following recom-
mendations can be made:
1. The choice of platform depends on the design of the
experiment. Illumina microarrays can be more appropri-
ate for models with large transcriptomic differences,
whereas Affymetrix have a larger dynamic range.
2. For Affymetrix studies, the choice of signal extraction
significantly affects reproducibility. RMA performs well in
all tests, whereas MAS 5.0 and the Li-Wong method have
high accuracy and sensitivity in detecting highly differen-
tially expressed genes.
3. Filtering results on intensity level, through platform-
specific present calls, is very important for obtaining reli-
able data.
4. In agreement with published findings [6], for moderate
sample sizes, comparing gene lists through p values leads
to an observed low concordance of results between data-
sets, due to the reliance of the t-test statistic on the unsta-
ble estimate of sample error, and the comparison of
observed fold changes is recommended.
5. Comparing platforms on a gene-level summary basis
rather than individual nucleotide or accession number
improves data reproducibility for the arrays studied.
Methods
Animals and RNA sample preparation
Male mice of the inbred strain C57BL/6JOxjr were bred
locally using stocks from the Jackson laboratory. They are
referred as C57BL/6 throughout the text. Mice were fed a
normal carbohydrate (CHD) diet (S&K Universal Ltd,
Hull, UK) or a 40% high fat diet (HFD) (Special Diet Serv-
ices, Witham, UK) ad libitum as previously described [25].
For the rat data set, we used biopsies of male inbred rats
of the diabetic Goto-Kakizaki (GK) strain [26], the nor-
moglycaemic Brown-Norway (BN) and Wistar-Kyoto
(WKY, also referred as W in this study) strains, and WKY
rats made diabetic (approximately 16 mM) by intrave-
nous injection of a solution of Streptozotocin (Sigma-
Aldrich, Poole, UK) at 75 mg/kg in citrate buffer (WKY-
STZ rats also referred as STZ throughout the article). Rats
of the GK and BN strains were from the Oxford colony
(GK/Ox, BN/Ox) and WKY rats were purchased from a
commercial supplier (Harlan, UK). All animals were kept
under identical standard maintenance conditions on 12 hPage 8 of 13
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accordance with national guidelines.
Organs used for gene expression profiling were chosen for
their role in glucose homeostasis (liver) and diabetic com-
plications (kidney). Total RNA was prepared from liver
(mice and rats) and kidney (rat) biopsies as previously
described [25].
Microarray hybridisation
Targets prepared from C57/Bl6 mice (n = 5 per diet group)
were individually hybridised to both Affymetrix® Gene-
Chip® Mouse Genome 430 2.0 arrays, which contain
45,101 probe sets, and Illumina® Sentrix® BeadChip
Mouse-6 Expression arrays (Beta Version 1), which con-
tain 46,120 distinct oligonucleotide sequences.
Three separate types of microarray were used to carry out
rat gene expression profiling:
- Operon Rat v1.0 OpArray™ is a two-colour gene expres-
sion system, containing 5,717 oligonucleotides, almost
entirely representative for unique well-documented genes.
A full factorial dye-swap design was implemented, where
a target from each animal's mRNA was hybridised on a
separate array with all animals from different strains, and
each array was repeated with the corresponding dyes
switched, to correct for dye biases. A total of 108 slides
were used for the liver experiment and 54 for the kidney,
as three animals per group were used. RNA from WKY-STZ
kidneys were not used on this array type.
- Affymetrix® GeneChip® Rat Expression Set 230A Gene-
Chip® arrays contain 15,923 probe sets, corresponding to
over 10,000 distinct annotated genes. A total of twelve
microarrays were hybridised using samples from three
animals for each of the four groups.
- Beta test version of the Illumina® Sentrix® BeadChip
RatRef-12_V1_Eval Expression microarrays carry twelve
arrays for every slide, and each array contained 22,612 dis-
tinct oligonucleotides. Technical replicates were used for
all samples.
All experiments are MIAME compliant. Protocols and data
are available through ArrayExpress http://www.ebi.ac.uk/
arrayexpress/ under the accession E-MEXP-1195 (Rat kid-
ney transcriptome on Affymetrix), E-MEXP-889 (Rat liver
transcriptome on Affymetrix), E-TABM-500 (Rat kidney
transcriptome on Operon), E-TABM-502 (Rat kidney tran-
scriptome on Illumina), E-MEXP-1755 (C57BL/6J mouse
liver transcriptome on Affymetrix).
Background removal and signal extraction techniques
These techniques are very platform-dependent because of
the various background measurement techniques and
scanning technologies. Different signal extraction tech-
niques, especially for the Affymetrix platform, are
expected to be less comparable than different between-
array normalisations applied to the same signal extrac-
tion, as the extraction models glean distinct information
from the raw foreground (and background) intensities,
whereas the normalisation methods seek to minimise dis-
tribution differences through global corrections. For
Operon arrays we used background subtraction, Normal
and Exponential Convolution model (normexp) [27],
and methods proposed by Kooperberg et al. [28] and
Edwards [29]. For Affymetrix arrays, we applied the micro-
array Suite version 5.0 (MAS 5.0) [30], the model-based
expression indexes (MBEI) [31,32] (Li-Wong method),
the Robust Multi-Array Analysis (RMA) [23], the GC-RMA
method [24], using the raw Perfect Match values with no
background corrections [33]. Finally, the Illumina plat-
form does not directly measure any background or non-
specific hybridisation control. However, this platform has
been shown to have high precision (Kuhn et al. 2004) and
is analysed, by default, with no background removal tech-
nique.
The variance stabilisation (vsn) method [34] was used for
both within- and between-array calibration, and was used
for data generated by all three platforms. We used scale
transformation [35], quantile normalisation [36], local
regression (loess) [35], including print-tip loess normali-
sation for Operon [35] and cubic spline fitting [37]. All
calculations used were either conducted in the R Language
and Environment for Statistical Computing (R) [38] or
the Illumina® BeadStudio® software. All the R normalisa-
tions were implemented in the "LIMMA" [27], "affy" [39]
or "vsn" [34] R packages.
Data validation by quantitative RT-PCR
Quantitative Real-Time Polymerase Chain Reaction (qRT-
PCR) was performed for a total of 17 genes with kidney
samples from all four rat models. Genes were selected pri-
marily due to differential expression in either the Affyme-
trix or Operon-generated rat kidney microarray data sets.
Experiments were conducted using samples from the
same animals as profiled with microarrays, and technical
triplicates were used for all genes. Actin was used as the
control "house-keeping" gene.
Gene annotations in the array systems
We labelled as cross-platform "target matches", sets where
the oligonucleotide sequence of a probe aligned identi-
cally to the sequence spanned by all probes of an Affyme-
trix probe set. Dai et al. observed that Affymetrix probe set
design for each microarray could not evolve as thePage 9 of 13
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time, and that, in some cases, probes in the same probe set
derived from distinct genes [40]. They created new anno-
tation files based on public annotations, and claim 30–
50% discrepancy in genes previously identified as differ-
entially-expressed. Due to the redundancy in most other
databases, alignments to Ensembl genes were used. The
new probe sets are formed by identifying all perfect match
(PM) probes which have a unique identical match
amongst Ensembl genes, and forcing the new probe sets to
contain at least three probes.
Publicly available gene annotations were used http://
brainarray.mbni.med.umich.edu/Brainarray/Database/
CustomCDF. For Illumina and Operon, no such annota-
tions existed in the literature. However, as on both these
platforms oligonucleotides in a set are identical, we
aligned all probes against Ensembl genes http://
oct2005.archive.ensembl.org, with the version used for
the Affymetrix probe sets, to ensure the same genome
builds were consistently used (Mouse NCBI m34 and Rat
RGSC 3.4).
Statistical issues
Prior to analysis, the data was filtered by removing a user-
specified proportion of oligonucleotides with the lowest
mean log2 intensity in the comparison of interest. Only
matches where at least one oligonucleotide from each
platform under investigation remained after filtering were
used.
As different signal extractions and normalisations pro-
duce outputs in absolute or logarithmic values (in varying
bases), all expression intensities and fold changes from all
platforms were converted into logarithmic (base 2) values
after normalisation. This transformation converts multi-
plicative effects (such as fold changes in gene expression)
into additive effects, which increases ease of both analysis
and interpretation [41]. Pearson correlations were used
throughout this study. The correlation in intensity is less
indicative than the correlation in fold change, as different
platforms will have differing hybridisation efficiencies
that may be sample dependent, or vary more through dif-
ferent normalisation techniques, but the intensity should
be proportional to the abundance of mRNA in the sam-
ple, so fold changes should be conserved.
We also investigated whether the platforms produce the
same genes as most worthy of investigation, if one only
considers the "top" genes ranked by either most signifi-
cant p value or highest absolute fold change. Although
any overlap is likely to be very highly pointwise significant
when compared to the null hypothesis of no relation
between the platforms, whether the agreement is suffi-
cient to be biologically useful is difficult to assess.
When comparing all three platforms, three pairwise tables
would have to be created. In order to illustrate all intra-
platform concordances simultaneously, a new plot which
was labelled a "dartboard plot" was specifically designed
(Figures 3 and 4). The platforms in large block capitals
have their lists entered radially from the circumference,
and apply until the thick black lines, the other platforms
are to either side of the dotted line and their lists move out
from the dotted line. The segments, corresponding to
using all or part of the dataset, are colour-coded so that
red marks the maximum possible value for that segment,
i.e. the minimum of the two list sizes, and white repre-
sents 50% or fewer matches. Note that segments on either
side of a thick black line use the same data.
It must be emphasised that when compiling these con-
cordance lists, only oligonucleotides or genes which
match to the other platform or platforms are included,
implying there are no missing values, so that the above
statistics can be applied and the lists directly compared for
their technical performance. However, this is an impor-
tant concern for experimental reasons; if two platforms
show high concordance for genes assayed on both, but
one measures the expression of many more genes, the two
will not be of equivalent biological value. For the mouse
experiment, the Affymetrix and Illumina microarrays had
very similar oligonucleotide numbers, while in the rat the
Operon platform had fewer oligonucleotides and the
Affymetrix GeneChip utilised was designed in a prior gen-
eration of feature size to the Illumina BeadChip, so fewer
probe sets were present. Hence for a valid comparison,
only matching oligonucleotides were used. In general,
similar generation Affymetrix and Illumina microarrays
contain similar oligonucleotide numbers.
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Additional file 1
Scatterplots of mouse target log2 fold changes for Illumina (y) against 
Affymetrix (x) for most normalisations for the 25% most intense oli-
gonucleotides. Effects of normalisation methods on gene expression 
changes derived by Illumina and Affymetrix.




Scatterplots of all rat Ensembl Gene match log2 fold changes between 
Affymetrix (normalised by RMA), Illumina (normalised by loess for 
liver and quantile normalisation for kidney) and Operon (normalised 
by vsn and quantile normalisation) for all tissues and strain compar-
isons. Analysis of rat gene expression changes for genes represented on the 
Illumina, Affymetrix and Operon arrays.




Scatterplots of Rat Ensembl Gene match log2 fold changes between 
Affymetrix (normalised by RMA), Illumina (normalised by loess for 
liver and quantile normalisation for kidney) and Operon (normalised 
by vsn and quantile normalisation) for all tissues and strain compar-
isons, restricting analysis to the 25% most intense genes on each plat-
form (approximately 320 genes). Analysis of the magnitude of rat gene 
transcription changes for genes represented on the Illumina, Affymetrix 
and Operon arrays and showing strong level of expression.




Gradient of log2 fold change scatterplots of Illumina (y) against 
Affymetrix (x) mouse "Target matches" for all normalisations, 
restricting analysis to the 25% most intense oligonucleotides (approx-
imately 2,700 oligonucleotides). Effects of various normalisation meth-
ods on mouse gene expression changes generated by Illumina and 
Affymetrix arrays.




Concordance of all mouse Affymetrix and quantile normalised Illu-
mina unique "Target match" p value data between different Affyme-
trix normalisations (8,886 matches). Comparative analysis of statistical 
significance of mouse gene expression data derived by Illumina and 
Affymetrix arrays.




Concordance of all mouse Affymetrix and quantile normalised Illu-
mina unique "Target match" fold change data between different 
Affymetrix normalisations (8,886 matches). Comparative analysis of 
the magnitude of mouse gene expression changes derived by Illumina and 
Affymetrix arrays.




Total concordance in top X fold change lists between Affymetrix (nor-
malised by GC-RMA), Illumina (normalised by loess for liver data 
and quantile for kidney data) and Operon (vsn and scale) for both 
tissues and all comparisons, using unfiltered (1,804 genes) and top 
25% intensity-based filtering (approximately 280 genes). Comparative 
analysis of the magnitude of rat gene expression changes derived by Illu-
mina, Affymetrix and Operon arrays.




Total concordance in top X p value lists between Affymetrix (normal-
ised by scale and median polish), Illumina (loess) and Operon (vsn 
and scale) for both tissues and all comparisons, using unfiltered 
(1,502 genes) and top 25% intensity-based filtering (approximately 
280 genes). Comparative analysis of the statistical significance of rat gene 
expression changes derived by Illumina, Affymetrix and Operon arrays.




Correlation in log2 fold change between qRT-PCR and all Affymetrix 
normalisations by strain comparison for all seventeen genes in rat kid-
ney. Comparative analysis of gene expression changes given by quantita-
tive RT-PCR and Affymetrix array data normalised using several methods.




Correlation in log2 fold change between qRT-PCR and all Illumina 
normalisations by strain comparison for all seventeen genes in rat kid-
ney. Comparative analysis of gene expression changes given by quantita-
tive RT-PCR and Illumina array data normalised using several methods.




Correlation in log2 fold change between qRT-PCR and all Operon 
normalisations by strain comparison for all seventeen genes in rat kid-
ney. Comparative analysis of gene expression changes given by quantita-
tive RT-PCR and Operon array data normalised using several methods.
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